Product Name: Brexpiprazole
Structure:

CAS NO: 913611-97-9
Specification: In-house
Documents: MSDS；Tech Package
Usage: a novel atypical antipsychotic drug.
Supplementary information: The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression